Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease
Launched by STANFORD UNIVERSITY · Mar 11, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding a specific issue that some patients with Moyamoya Disease experience after surgery. It aims to find out how often patients have what are called Transient Neurologic Events (TNEs) in the first 30 days after their surgery. TNEs are temporary neurological problems that can occur following surgery. The researchers will look at various factors during the recovery period to see what might cause these episodes and how they can be minimized.
To participate in this study, individuals must be diagnosed with Moyamoya Disease and are scheduled to undergo a specific type of surgery called extracranial-intracranial bypass, which helps improve blood flow to the brain. Anyone aged 3 years and older can join, as long as they do not have certain other health issues like kidney problems or certain heart conditions. Participants can expect to have their recovery monitored closely for a month after surgery, helping doctors learn more about how to support patients during this critical time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Moyamoya Disease (MMD) patients undergoing direct extracranial-intracranial (ECIC) bypass. Patients above the age of 3 years old are eligible for the study
- Exclusion Criteria:
- • Renal dysfunction, electrolyte disturbances neuromuscular disorders including Myaesthenia Gravis, heart block
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported